-+ 0.00%
-+ 0.00%
-+ 0.00%

SAB Biotherapeutics Price Target Raised to $10.00/Share From $7.00 by HC Wainwright & Co.

Dow Jones·05/12/2026 17:04:00

Please log in to view news